LIFECORE BIOMEDICAL, INC. \DE\ Insider Trading Activity
Every SEC Form 4 insider transaction reported for LIFECORE BIOMEDICAL, INC. \DE\ (LFCR), sourced directly from SEC EDGAR and updated as new filings are accepted.
Quick Answer
Are LFCR insiders buying or selling?
LIFECORE BIOMEDICAL, INC. \DE\ insiders reported 47 open-market buys ($27.0M) and 5 sells ($10.0M) across 52 Form 4 filings — a net buying position of $17.0M.
Source: SEC EDGAR Form 4
Key Statistics (as of May 29, 2025)
Insider sentiment
Net buyingNet insider flow of $17.0M in net buying.
Recent LFCR insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| May 29, 2025 | Aron R. English | 10% Owner | Sale | 1.4M | $6.59 | $9.1M |
| May 16, 2025 | Aron R. English | 10% Owner | Sale | 12.3K | $7.00 | $86.4K |
| May 12, 2025 | Aron R. English | 10% Owner | Sale | 51.5K | $7.03 | $362.0K |
| May 8, 2025 | Aron R. English | 10% Owner | Sale | 41.1K | $7.05 | $289.9K |
| Jan 8, 2025 | Paul Josephs | Chief Executive Officer | Purchase | 17.0K | $5.74 | $97.6K |
| Oct 8, 2024 | Nelson Obus | 10% Owner | Purchase | 292.7K | $4.10 | $1.2M |
| Oct 7, 2024 | Christopher S Kiper | Director, 10% Owner | Purchase | 1.5M | $4.10 | $6.0M |
| Jan 18, 2023 | Nelson Obus | 10% Owner | Purchase | 627.7K | $7.97 | $5.0M |
| Oct 26, 2022 | Nelson Obus | 10% Owner | Purchase | 250.0K | $8.09 | $2.0M |
| Jan 14, 2022 | Nelson Obus | 10% Owner | Purchase | 387.4K | $10.41 | $4.0M |
| Jan 14, 2022 | Joshua Schechter | Director | Purchase | 10.0K | $10.39 | $103.9K |
| Apr 22, 2021 | Patrick D Walsh | Director | Purchase | 10.0K | $11.26 | $112.6K |
| Apr 21, 2021 | Timothy P Burgess | Senior VP of Supply Chain | Purchase | 5.0K | $9.99 | $50.4K |
| Apr 20, 2021 | John D Morberg | Chief Financial Officer | Purchase | 2.0K | $11.05 | $22.1K |
| Apr 19, 2021 | John D Morberg | Chief Financial Officer | Purchase | 2.0K | $11.08 | $22.2K |
| Apr 16, 2021 | John D Morberg | Chief Financial Officer | Purchase | 2.0K | $10.98 | $22.0K |
| Apr 15, 2021 | Albert D. Bolles | Chief Executive Officer | Purchase | 9.0K | $10.61 | $95.5K |
| Apr 15, 2021 | James G Hall | Vice President | Purchase | 10.0K | $10.62 | $106.2K |
| Apr 15, 2021 | John D Morberg | Chief Financial Officer | Purchase | 2.0K | $10.64 | $21.3K |
| Apr 15, 2021 | Nelson Obus | 10% Owner | Purchase | 240.6K | $10.02 | $2.4M |
| Apr 14, 2021 | Nelson Obus | 10% Owner | Purchase | 240.6K | $10.02 | $2.4M |
| Apr 13, 2021 | John D Morberg | Chief Financial Officer | Purchase | 2.0K | $10.18 | $20.4K |
| Feb 12, 2021 | John D Morberg | Chief Financial Officer | Purchase | 1.4K | $11.88 | $16.6K |
| Feb 11, 2021 | John D Morberg | Chief Financial Officer | Purchase | 2.0K | $11.64 | $23.3K |
| Feb 10, 2021 | John D Morberg | Chief Financial Officer | Purchase | 2.0K | $12.06 | $24.1K |
Showing the 25 most recent of 52 Form 4 filings for LIFECORE BIOMEDICAL, INC. \DE\.
Most active LFCR insiders
- Nelson Obus16 filings
- John D Morberg10 filings
- Nelson Obus6 filings
- Aron R. English4 filings
- Albert D. Bolles3 filings
Ask anything about LFCR insider activity
Use Trabud's AI agent to query LIFECORE BIOMEDICAL, INC. \DE\'s Form 4 history in plain English — "Show me LFCR CEO purchases this year" or compare it against any other ticker.
Open the AI agentLFCR insider trading FAQ
Are LIFECORE BIOMEDICAL, INC. \DE\ insiders buying or selling?
Across 52 SEC Form 4 filings, LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) insiders reported 47 open-market purchases totaling $27.0M and 5 sales totaling $10.0M. That is a net buying position of $17.0M.
How many insiders trade LFCR stock?
17 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for LIFECORE BIOMEDICAL, INC. \DE\. The most recent filing was accepted on May 29, 2025.
Where does Trabud get LFCR insider trading data?
All LFCR insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.